Compounded hormone cream: check the beyond-use date
An advertised supply period does not establish that a compounded hormone cream can be used throughout that period. Ask the pharmacy how its beyond-use date fits the prescribed quantity and shipping schedule.
What this comes down to
- Get the actual beyond-use date and storage instructions from the dispensing pharmacy.
- Compare the usable period with the supply you are paying for.
- Ask about replacement shipments before committing to a longer package.
Two dates describe different things
FDA explains that expiration dating for approved drug products relies on stability data and specified storage. Compounded preparations have their own dating considerations. USP's publicly accessible stability reference preview discusses studies used to establish or extend beyond-use dates; it explicitly says it is not the official enforceable chapter text. Neither source gives you a universal number of usable days for every compounded hormone cream.[1][2]
The EstroGel label gives storage instructions for that specific product. Those instructions do not establish a storage rule for your compounded cream. Obtain the storage directions for the preparation your pharmacy dispenses, along with the beyond-use date.[5]
Ask about your actual preparation
FDA notes that compounded drugs are not FDA approved. An approved product's dating cannot simply be assigned to a custom cream. Ask the pharmacy for the label's beyond-use date, storage conditions and any instructions that apply after opening. Specify the formulation, device and quantity in the quote. If the service gives only a subscription duration, ask it to obtain the preparation's details from the pharmacy.[3]
| Item | Ask the pharmacy |
|---|---|
| Beyond-use date | Which date applies to this dispensed preparation? |
| Opening instructions | Does opening change any use or storage instruction? |
| Shipment quantity | Will the quantity fit the usable period at the prescribed directions? |
| Delivery or label problem | Who handles replacement, and what reporting deadline applies? |
Dates to keep with the quote
Check whether the purchased quantity fits the date
California's nonsterile compounding FAQ requires a pharmacy to retain a referenced source supporting an assigned beyond-use date. That is a California documentation requirement, not a nationwide cream-duration rule. The useful purchasing question everywhere is which date and instructions apply to the dispensed preparation. Ask whether the pharmacy plans several shipments so each usable period fits the prescription, rather than assuming a prepaid package means one long-lasting container.[4]
Clarify the remedy before paying
Request a written answer about when the cream is prepared, expected delivery, quantity in each shipment and what happens if the usable period does not cover the promised prescribed supply. Ask who pays for a replacement or additional shipment and how to report a label or delivery issue. Those are purchasing questions, not a promise that any particular pharmacy must offer a refund. Save the label and order terms together. Do not extend use past the labeled date or change storage to stretch the purchase; ask the pharmacist to resolve a mismatch.
For the broader purchasing background, read verifying a compounding pharmacy.
Questions people actually ask
Is a beyond-use date the subscription renewal date?
No. One concerns the preparation; the other concerns payment. Ask the service and pharmacy how the two fit together.
Does every compounded cream have the same usable period?
The cited public sources do not establish one universal period. Obtain the date for the actual preparation.
Does paying for a longer plan guarantee one container lasts that long?
No. Ask whether the plan uses multiple shipments and how each shipment's usable period matches the prescribed supply.
Sources
Primary sources and the claims they support.
- 1.Expiration dates: questions and answers. FDA, Undated. SourceExpiration dating for approved products is supported by stability data and storage conditions.
- 2.Stability reference document for pharmaceutical compounding: preview. USP, 2024. SourceThe public preview explains stability studies and BUDs; it is not an enforceable chapter or a universal BUD table.
- 3.Compounding and FDA: questions and answers. FDA, Undated. SourceCompounded medicines are not FDA approved; product approval is separate from pharmacy regulation.
- 4.Nonsterile compounding FAQ: BUD documentation. California Board of Pharmacy, 2026. SourceCalifornia's nonsterile FAQ requires pharmacies to retain sources supporting assigned BUDs; not a nationwide duration.
- 5.EstroGel metered gel label. DailyMed / ASCEND, 2026. Source · Document dated May 2026Product-specific 50 g container, 30 metered actuations, 1.25 g gel and 0.75 mg estradiol per actuation; labeled storage instructions.